1 / 8

Adult Still’s Disease

Adult Still’s Disease. Maggie Davis Hovda, MD 3/22/2010. About. Adult equivalent to Juvenile RA Diagnosis of exclusion Characterized by: Fevers, arthritis, rash. Etiology. Unknown Suggestions Infectious: Viral, Bacterial (mycoplasma, yersinia)

sela
Télécharger la présentation

Adult Still’s Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Adult Still’s Disease Maggie Davis Hovda, MD 3/22/2010

  2. About • Adult equivalent to Juvenile RA • Diagnosis of exclusion • Characterized by: Fevers, arthritis, rash

  3. Etiology • Unknown • Suggestions • Infectious: Viral, Bacterial (mycoplasma, yersinia) • Genetics: certain HLA markers associated with disease, but none substantively so

  4. Epidemiology • No gender preference • Two age peaks • 15 – 25 • 36 – 46

  5. Classification Criteria • Yamaguchi Criteria • 5 total: 2 major + 2 minor • Major • Quotidian Fever > 39 for at least 1 week • Arthralgias/Arthritis at least 2 weeks • Rash • Wbc > 10,000 with PMN predominance • Minor • Pharyngitis • LAD • Abnormal LFTs • Negative ANA, RF • Other: pericarditis, pleural effusions, Reactive HS

  6. Laboratory Evaluation • Ferritin > 3,000

  7. Clinical Course • Monophasic: symptoms < 1 year • Intermittent: more than one flare with total symptom remission in between • Chronic: chronic, active disease • Predictors: develop polyarthritis early in course, shoulder and hip involvement, > two years of glucocorticoid therapy

  8. Treatment • NSAIDS – mild disease • Steroids – most patients • Biologics – TNFa inhibitors, anakinra, rituximab • DMARDS – cyclosporine, MTX

More Related